Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial von van Dam, J L, Verkolf, E M M, Dekker, E N, Bonsing, B A, Bratlie, S O, Brosens, L A A, Busch, O R, van Driel, L M J W, van Eijck, C H J, Feshtali, S, Ghorbani, P, de Groot, D J A, de Groot, J W B, Haberkorn, B C M, de Hingh, I H, van der Holt, B, Karsten, T M, van der Kolk, M B, Labori, K J, Liem, M S L, Loosveld, O J L, Molenaar, I Q, Polée, M B, van Santvoort, H C, de Vos-Geelen, J, Wumkes, M L, van Tienhoven, G, Homs, M Y V, Besselink, M G, Wilmink, J W, Groot Koerkamp, B

Volltext

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2... von Janssen, Q P, van Dam, J L, Bonsing, B A, Bos, H, Bosscha, K P, Coene, P P L O, van Eijck, C H J, de Hingh, I H J T, Karsten, T M, van der Kolk, M B, Patijn, G A, Liem, M S L, van Santvoort, H C, Loosveld, O J L, de Vos-Geelen, J, Zonderhuis, B M, Homs, M Y V, van Tienhoven, G, Besselink, M G, Wilmink, J W, Groot Koerkamp, B

Volltext

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePr... von Meulenbeld, H.J, van Werkhoven, E.D, Coenen, J.L.L.M, Creemers, G.J, Loosveld, O.J.L, de Jong, P.C, ten Tije, A.J, Fosså, S.D, Polee, M, Gerritsen, W, Dalesio, O, de Wit, R

Volltext

Real Life Data and Outcome of FOLFIRINOX Use in Metastatic Pancreatic Cancer Patients in General Hospitals in the Netherlands von Haberkorn, B.C.M., Hoogendijk, L., Loosveld, O.S., Thijs, A. M. J., Verstijnen, J.

Volltext

Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older von van Erning, F.N., Creemers, G.J., De Hingh, I.H.J.T., Loosveld, O.J.L., Goey, S.H., Lemmens, V.E.P.P.

Volltext

Effectiveness of a Tailored Work-Related Support Intervention for Patients Diagnosed with Gastrointestinal Cancer: A Multicenter Randomized Controlled Trial von Zaman, A. C. G. N. M., Tytgat, K. M. A. J., Klinkenbijl, J. H. G., Boer, F. C. den, Brink, M. A., Brinkhuis, J. C., Bruinvels, D. J., Dol, L. C. M., van Duijvendijk, P., Hemmer, P. H. J., Lamme, B., Loosveld, O. J. L., Mok, M. M., Rejda, T., Rutten, H., Schoorlemmer, A., Sonneveld, D. J., Stassen, L. P. S., Veenstra, R. P., van de Ven, A., Velzing, E. R., Frings-Dresen, M. H. W., de Boer, A. G. E. M.

Volltext

Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice von Razenberg, L G E M, van Gestel, Y R B M, de Hingh, I H J T, Loosveld, O J L, Vreugdenhil, G, Beerepoot, L V, Creemers, G J, Lemmens, V E P P

Volltext

Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008 von Lemmens, V. E. P. P, de Haan, N, Rutten, H. J. T, Martijn, H, Loosveld, O. J. L, Roumen, R. M. H, Creemers, G. J. M

Volltext

Variable workup calls for guideline development for type 2A hereditary haemochromatosis von Smit, S L, Peters, T M A, Gisbertz, I A M, Moolenaar, W, Hendriks, Y, Vincent, H H, Houtsma, D, Loosveld, O J L, van Herwaarden, A E, Rennings, A J M, Swinkels, D W

Volltext

Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC) von van Rooijen, K L, Kurk, S A, van der Kruijssen, D E W, Elias, S, May, A M, Cats, A, Creemers, G-J M, Erdkamp, F L G, Loosveld, O J, Rodenburg, C J, Tanis, P J, Vink, G R, de Wilt, J H W, Punt, C J A, Koopman, M

Volltext

RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY von Lugtenburg, P., Nully Brown, P., Holt, B., d'Amore, F., Koene, H., Jongh, E., Fijnheer, R., Loosveld, O., Böhmer, L., Pruijt, H., Verhoef, G., Hoogendoorn, M., Bilgin, Y., Nijland, M., Lam, K., Keizer, B., Jong, D., Zijlstra, J.

Volltext

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy von Lalisang, R. I., Erdkamp, F. L. G., Rodenburg, C. J., Knibbeler-van Rossum, C. T. A. M., Nortier, J. W. R., van Bochove, A., Slee, P. H. Th. J., Voest, E. E., Wils, J. A., Wals, J., Loosveld, O. J. L., Smals, A. E. M., Blijham, G. H., Tjan-Heijnen, V. C. G., Schouten, H. C.

Volltext

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch C... von van der Kruijssen, D. E.W, Elias, S. G, van de Ven, P. M, van Rooijen, K. L, Lam-Boer, J. ’t, Mol, L, Punt, C. J.A, Sommeijer, D. W, Tanis, P. J, Nielsen, J. D, Yilmaz, M. K, van Riel, J. M.G.H, Wasowiz-Kemps, D. K, Loosveld, O. J.L, van der Schelling, G. P, de Groot, J. W.B, van Westreenen, H. L, Jakobsen, H. L, Fromm, A. L, Hamberg, P, Verseveld, M, Jaensch, C, Liposits, G. I, van Duijvendijk, P, Oulad Hadj, J, van der Hoeven, J. A.B, Trajkovic, M, de Wilt, J. H.W, Koopman, M, van Grevenstein, W. M.U.Helma, CAIRO4 Working Group

Volltext

Abdominal pain with unexpected pulmonary consequences von VAN BERKEL-MIJNSBERGEN, J. Y, LOOSVELD, O. J. L, VOS, L. D

Volltext

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer von Dekker, E. N, Busch, O. R, Labori, K. J, Haberkorn, B. C. M, van der Holt, B, Wilmink, J. W, Feshtali, S, Besselink, M. G, van Eijck, C. H. J, van Tienhoven, G, van der Kolk, M. B, van Dam, J. L, Bratlie, S. O, Liem, M. S. L, de Hingh, I. H, Homs, M. Y. V, de Vos - Geelen, J, de Groot, J. W. B, Polée, M. B, de Groot, D. J. A, van Santvoort, H. C, Bonsing, B. A, Verkolf, E. M. M, Karsten, T. M, Groot Koerkamp, B, Ghorbani, P, van Driel, L. M. J. W, Molenaar, I. Q, Brosens, L. A. A, Loosveld, O. J. L, Wumkes, M. L

Volltext

Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized cont... von Janssen, Q., van Dam, J., Bonsing, B., Bos, H., Bosscha, K., Haberkorn, B., de Hingh, I., Karsten, T., van der Kolk, M., Liem, M., Loosveld, O., Patijn, G., van Santvoort, H., de Vos - Geelen, J., van der Holt, B., Homs, M., van Tienhoven, G., Besselink, M., Wilmink, J., Groot Koerkamp, B.

Volltext

530PInfluence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC) von van Rooijen, K L, Kurk, S A, van der Kruijssen, D E W, Elias, S, May, A M, Cats, A, Creemers, G-J M, Erdkamp, F L G, Loosveld, O J, Rodenburg, C J, Tanis, P J, Vink, G R, de Wilt, J H W, Punt, C J A, Koopman, M

Volltext

UGT1A128 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study von Kweekel, D M, Gelderblom, H, Van der Straaten, T, Antonini, N F, Punt, C J A, Guchelaar, H-J

Volltext

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas von van den Bent, M.J, Schellens, J.H.M, Vecht, Ch.J, Sillevis Smit, P.A.E, Loosveld, O.J.L, Ma, J, Tijssen, C.C, Jansen, R.L.H, Kros, J.M, Verweij, J

Volltext

S1599 RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY von Lugtenburg, P., Brown, P., Holt, B., D’Amore, F., Koene, H., Jongh, E., Fijnheer, R., Loosveld, O., Böhmer, L., Pruijt, H., Verhoef, G., Hoogendoorn, M., Bilgin, Y., Nijland, M., Lam, K., Keizer, B., Jong, D., Zijlstra, J.

Volltext